AXON

Q4 2025

Date: 2026-02-25Rank: #47Forward Promise: very_bullish

Axon delivered a record-breaking Q4 and full year 2025, with Q4 revenue growing 39% YoY to $797 million and full-year bookings surpassing $7 billion (up over 40%). Growth was broad-based, with Software and Services up 40% and Connected Devices up 38%, driven by new products like TASER 10, Body 4, and AI offerings. Adjusted EBITDA grew 46% YoY to $206 million with a 25.9% margin. Management raised 2026 revenue guidance to 27-30% YoY growth and introduced new 2028 targets targeting ~$6 billion in revenue and 28% adjusted EBITDA margins.

Bullishness Score

89.17

μ Mean

94.54

σ Uncertainty

1.79

Forward Promise

8.2

Management Tone

Management exhibited extremely high confidence and enthusiasm, frequently using superlatives like 'incredible,' 'best team,' and 'no better position.' The tone shifted from celebrating 2025 results to an aggressive, forward-looking focus on execution and AI disruption. There was a notable emphasis on 'leaning in' and taking risks rather than resting on laurels.

Confidence: HIGH — Management reaffirmed aggressive guidance, raised long-term targets, and dismissed concerns about software commoditization. They repeatedly emphasized visibility from record bookings and backlog.

Strategic Signals

Axon is aggressively pivoting to become an 'AI-first' company, leveraging its massive proprietary dataset (60M+ hours of footage) to build a defensible moat. The $750M in AI bookings suggests strong early traction for the AI Era Plan, which management believes will convert their existing hardware base into high-margin software subscribers.

The 2028 financial targets ($6B revenue, 28% EBITDA) imply a strategy of balancing continued heavy investment in R&D (new products like Apollo DART, VR, Drone mitigation) with operating leverage. The focus on 'Rule of 50+' metrics indicates a priority on sustainable, high-quality growth.

Significant strategic emphasis is being placed on expanding beyond core U.S. State & Local markets into Federal, International, Corrections, and Enterprise. The acquisition of Prepared and Carbyne signals a deliberate move to own the '911 to response' workflow, integrating call handling with sensor data.

Management views hardware as a critical strategic differentiator ('physical sockets') rather than a legacy burden. This integrated hardware-software approach is positioned as a competitive advantage against pure-play software vendors, particularly as AI commoditizes basic software features.

Key Metrics

Q4 Revenue$797M+39% YoY

2025 Bookings$7.4B+46% YoY

Q4 Adj. EBITDA$206M+46% YoY

Q4 Adj. EBITDA Margin25.9%+260 bps YoY

Net Revenue Retention125%Expansion

ARR$1.3B+35% YoY

2026 Revenue Guidance27-30%YoY Growth

Guidance

2026 Revenue Growth: 27% to 30% year-over-year

2026 Adj. EBITDA Margin: ~25.5%

2028 Revenue Target: ~$6 Billion

2028 Adj. EBITDA Margin: ~28%

Free Cash Flow Conversion: ~60% of Adj. EBITDA (long-term)

Bottom Line

Price Target: N/A

Axon is executing at a high level, successfully transitioning from a hardware vendor to a high-margin AI-driven platform. The Q4 results and 2026 guidance demonstrate that the company is benefiting from a powerful product cycle (TASER 10, Body 4) and early AI monetization. The shift to 2028 targets ($6B revenue) provides a clear roadmap. The core risk is valuation, but the fundamental momentum—evidenced by 40%+ bookings growth and 125% NRR—supports a premium multiple. The expansion into Federal and Enterprise markets via Dedrone and 911 (Prepared/Carbyne) provides incremental growth vectors that are just starting to contribute.

Forward Promise

Overall: 8.2 · very_bullish

Firing on all cylinders with record backlog and AI momentum.

Management displayed exceptional confidence backed by record bookings and margin expansion, signaling a multi-year growth runway driven by AI and new markets.

Red Flags

Tariff and inflationary pressure impacted gross margins in Q4 (down sequentially), and management expects continued headwinds from global tariffs and component costs (memory) in 2026, which could dampen margin expansion if not offset by pricing or mix.

Free cash flow conversion decreased year-over-year due to inventory investments and timing of collections. While management expects a rebound, the elevated capital needs for scaling manufacturing capacity and new product introductions represent a use of cash that limits immediate returns.

The company is navigating complex ethical and privacy landscapes regarding AI and drone usage. Management explicitly identified a 'misstep around privacy and data handling' as a top risk, acknowledging that public sentiment or regulatory changes could impact adoption.

Valuation risk is implied by the aggressive growth expectations; the stock trades on high multiples of revenue, and the 27-30% growth target for 2026 leaves little room for execution errors or macroeconomic slowdowns in government spending.

Macro Insights

Government Spending: Management indicated that state and local budgets remain robust, with no signs of slowing demand despite broader economic concerns.

Regulatory Environment: The administration is described as 'very open to modernizing policy around drones,' suggesting a favorable tailwind for the Dedrone/Counter-UAS business.

Tariffs/Supply Chain: Management noted a 15% global tariff is baked into guidance, but refunds are uncertain, representing a potential headwind to margins if not resolved.